6937-38-8

Basic information

• Product Name: (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one
• CAS NO: 6937-38-8
• Molecular Formula: C₁₇H₁₃NO
• Molecular Weight: 247.2912
• Mol File: 6937-38-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 465.8°C at 760 mmHg
• Flash Point: 239.1°C
• Density: 1.222g/cm³
• Vapor Pressure: 7.45E-09mmHg at 25°C
• Refractive Index: 1.714
• CAS DataBase Reference: (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one(6937-38-8)
• EPA Substance Registry System: (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one(6937-38-8)

Safety Data

• Hazardous Substances Data: 6937-38-8(Hazardous Substances Data)

Usage

General Description

(2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one is a chemical compound with the chemical formula C16H13NO. It is a ketone derivative with a phenylpropenone structure and an indole group. (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one is of interest due to its potential biological and pharmacological activities, as it is a key structural component in many natural products and pharmaceutical compounds. Research has shown that compounds containing an indole moiety have diverse pharmacological activities, including antimicrobial, anti-inflammatory, and anticancer properties. Additionally, the phenylpropenone group has been found to have potential as a therapeutic agent for various diseases. Therefore, (2E)-1-(1H-indol-3-yl)-3-phenylprop-2-en-1-one has the potential for various applications in the fields of medicine, pharmaceuticals, and biological research.

Upstream product

• 120-72-9 indole 
• 102-92-1 cinnamoyl chloride 
• 703-80-0 3-acetylindole 
• 100-52-7 benzaldehyde 

Downstream Products

• 639085-67-9 8-(1H-indol-3-yl)-6-phenyl-6,7-dihydro-5-oxa-9-aza-benzocycloheptene 
• 639085-63-5 4-(1H-indol-3-yl)-2-phenyl-2,3-dihydro-benzo[b][1,4]thiazepine 
• 716305-05-4 1-[3-(1H-indol-3-yl)-5-phenyl-4,5-dihydro-pyrazol-1-yl]-ethanone 

Relevant articles and documents

Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies

The synthesis of novel indolopyrazoline derivatives (P1-P4 and Q1-Q4) has been characterized and evaluated as potential anti-Alzheimer agents through in vitro Acetylcholinesterase (AChE) inhibition and radical scavenging activity (antioxidant) studies. Sp

ALLOSTERIC PROTEIN KINASE MODULATORS

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

ALLOSTERIC PROTEIN KINASE MODULATORS

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.